Clinical TrialID 1242
Eucalyptus Oil as Adjuvant Therapy for Coronavirus Disease 19 (COVID-19)
NCT05398965
COVID-19
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Herb: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 1242
- Evidence Id
- 1242
- Core Evidence Id
- 1242
- Source Clinical Trial Id
- 1225
- Herb2 Clinical Trial Id
- HBCT001225
- Nct Id
- NCT05398965
- Title
- Eucalyptus Oil as Adjuvant Therapy for Coronavirus Disease 19 (COVID-19)
- Status
- Completed
- Phase
- Phase 2
- Study Result
- No
- Study Condition
- COVID-19
- Study Type
- Interventional
- Study Design
- Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
- Intervention
- DRUG: Eucalyptus Oil|DRUG: Standard COVID medication
- Intervention Allocation
- Randomized
- Intervention Model
- Parallel
- Intervention Mask
- Intervention Purpose
- Treatment
- Gender
- All
- Age
- Adult
- Enrollment
- 54
- Outcome Measure
- Clinical Symptoms, The patient will be asked for clinical improvement (three symptoms, sore throat, anosmia and cough) with a 6-likert scale question for each symptoms. Higher number (5) indicates very severe symptoms whereas 0 indicates no symptoms., change of score for each symptoms from baseline to day 15|Viral clearance, level of Severe Acute Respiratory Corona Virus 2 (SARS-COV2) on nasopharyngeal sample measured by RT-PCR in Cycle Threshold Unit (CT), change of CT Value from baseline to day 15|Neutrophil-Lymphocyte Ratio (NLR), This ratio is used as a marker of subclinical inflammation. It is calculated by dividing the number of neutrophils by number of lymphocytes from the blood sample, change of NLR from baseline to day 15
- Sponsor Collaborator
- Hasanuddin University|Ministry of Agriculture, Republic of Indonesia
- Funded By
- OTHER
- Location
- Hasanuddin University Hospital, Makassar, South Sulawesi, 90245, Indonesia
- Other Id
- 3105221321
- Start Date
- 2020-11-18
- Primary Completion Date
- 2021-01-28
- Completion Date
- 2022-03-01
- First Posted
- 2022-06-01
- Results First Posted
- Last Update Posted
- 2022-06-01
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT05398965
- Title Cn
- Title En
- Eucalyptus Oil as Adjuvant Therapy for Coronavirus Disease 19 (COVID-19)
- Bilingual Status
- semi_complete